ISEQ just behind positive bourses
Shares in Dublin lagged behind their European counterparts, although the ISEQ index did finish 52.84 points higher at 5232.42.
Elan Corporation rose over 4% after it was announced the firm intends to seek the approval of Antegren as a treatment for Crohn's disease in Europe. The stock gained 76c to close at €19.44. United Drug was also higher as it advanced 10c to €2.65.